SIRT5 and leukemia: Collectively, these results announced that upregulation of SIRT5 combined with THF utilization accounts for the inhibitory effects of the combined 6-MP and histidine treatment on leukemia cells, and that enzymatic activity is essential for SIRT5 to be effective.